Double-blind cross-over comparison of indomethacin, flurbiprofen, and placebo in ankylosing spondylitis.
作者信息
Sturrock R D, Hart F D
出版信息
Ann Rheum Dis. 1974 Mar;33(2):129-31. doi: 10.1136/ard.33.2.129.
Abstract
摘要
相似文献
1
Double-blind cross-over comparison of indomethacin, flurbiprofen, and placebo in ankylosing spondylitis.吲哚美辛、氟比洛芬与安慰剂治疗强直性脊柱炎的双盲交叉对照比较
Ann Rheum Dis. 1974 Mar;33(2):129-31. doi: 10.1136/ard.33.2.129.
2
Double-bind cross-over tiral of flurbiprofen and phenylbutazone in ankylosing spondylitis.氟比洛芬与保泰松治疗强直性脊柱炎的双盲交叉试验
Br Med J. 1974 Nov 30;4(5943):496-9. doi: 10.1136/bmj.4.5943.496.
3
Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with indomethacin.氟比洛芬治疗强直性脊柱炎。与吲哚美辛的比较。
Am J Med. 1986 Mar 24;80(3A):127-32. doi: 10.1016/0002-9343(86)90129-4.
4
A comparative study of benoxaprofen and indomethacin in ankylosing spondylitis.
J Rheumatol Suppl. 1980;6:139-42.
5
Management of ankylosing spondylitis with flurbiprofen or indomethacin.氟比洛芬或吲哚美辛治疗强直性脊柱炎
South Med J. 1977 Aug;70(8):945-7. doi: 10.1097/00007611-197708000-00014.
6
[Pirprofen, indomethacin and placebo in ankylosing spondylitis. Double-blind comparison].[吡洛芬、吲哚美辛与安慰剂治疗强直性脊柱炎。双盲比较]
Nouv Presse Med. 1982 Aug 28;11(33):2491-3.
7
A comparison of flurbiprofen and aspirin in the treatment of rheumatoid arthritis.氟比洛芬与阿司匹林治疗类风湿性关节炎的比较。
Med J Aust. 1974 Dec 28;2(26):925-7. doi: 10.5694/j.1326-5377.1974.tb93775.x.
8
A double-blind comparison of naproxen and indomethacin in rheumatoid arthritis.
Scand J Rheumatol. 1974;3(3):118-20. doi: 10.3109/03009747409097135.
9
Treatment of ankylosing spondylitis with flurbiprofen and indomethacin.氟比洛芬与吲哚美辛治疗强直性脊柱炎
Curr Med Res Opin. 1977;5(1):117-21. doi: 10.1185/03007997709108987.
10
[Naproxen--a new antiphlogistic].
Lakartidningen. 1974 Oct 3;71(40):3789-91.
引用本文的文献
1
Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis.泛美风湿病协会联盟关于治疗中轴型脊柱关节炎的建议。
Nat Rev Rheumatol. 2023 Nov;19(11):724-737. doi: 10.1038/s41584-023-01034-z. Epub 2023 Oct 6.
2
[Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].[关于轴向型脊柱关节炎（包括贝赫切雷夫病和早期形式）的S3指南长版，2019年更新：德国风湿病学会（DGRh）及参与的医学科学专业学会和其他组织的循证指南]
Z Rheumatol. 2019 Dec;78(Suppl 1):3-64. doi: 10.1007/s00393-019-0670-3.
3
Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).用于中轴型脊柱关节炎（强直性脊柱炎和非放射学中轴型脊柱关节炎）的非甾体抗炎药
Cochrane Database Syst Rev. 2015 Jul 17;2015(7):CD010952. doi: 10.1002/14651858.CD010952.pub2.
4
[Treatment of chronic back pain: current standards].[慢性背痛的治疗：当前标准]
Internist (Berl). 2014 Dec;55(12):1410-4, 1416-8. doi: 10.1007/s00108-014-3558-y.
5
[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.4 Pharmaceutical therapy, 8.5 Evaluation of therapy success of pharmaceutical measures].[德国风湿病学会关于包括贝赫切特病和早期形式的轴性脊柱关节炎的S3指南：8.4药物治疗，8.5药物治疗措施的疗效评估]
Z Rheumatol. 2014 Sep;73 Suppl 2:78-96. doi: 10.1007/s00393-014-1443-7.
6
Evaluation of the short-term efficacy of NSAIDs on patients with active ankylosing spondylitis in daily practice: a 3-month, longitudinal, observational study.评价 NSAIDs 在日常实践中对活动期强直性脊柱炎患者的短期疗效：一项为期 3 个月的纵向观察性研究。
Rheumatol Int. 2010 Jan;30(3):331-40. doi: 10.1007/s00296-009-0963-y. Epub 2009 May 23.
7
Safety and clinical responses in ankylosing spondylitis after three months of etanercept therapy.依那西普治疗三个月后强直性脊柱炎的安全性及临床反应
J Korean Med Sci. 2008 Oct;23(5):852-6. doi: 10.3346/jkms.2008.23.5.852.
8
Ankylosing spondylitis: recent breakthroughs in diagnosis and treatment.强直性脊柱炎：诊断与治疗的最新突破
J Can Chiropr Assoc. 2007 Dec;51(4):249-60.
9
Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis--a population-based survey.强直性脊柱炎中使用非甾体抗炎药——一项基于人群的调查。
Clin Rheumatol. 2006 Nov;25(6):794-800. doi: 10.1007/s10067-005-0132-y. Epub 2006 Mar 10.
10
Pharmacological treatment of ankylosing spondylitis: a systematic review.强直性脊柱炎的药物治疗：一项系统评价。
Drugs. 2005;65(15):2111-27. doi: 10.2165/00003495-200565150-00004.
本文引用的文献
1
Conferences and meetings: motivation in the physically disabled.会议：身体残疾者的动机
Br Med J. 1968 Apr 13;2(5597):111-2.
2
VALIDATION OF AN INVENTORY FOR MEASURING DEPRESSION.一份测量抑郁的量表的验证
Br J Psychiatry. 1965 Mar;111:240-2. doi: 10.1192/bjp.111.472.240.
3
An inventory for measuring depression.一份用于测量抑郁的量表。
Arch Gen Psychiatry. 1961 Jun;4:561-71. doi: 10.1001/archpsyc.1961.01710120031004.
4
DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.类风湿关节炎的诊断标准：美国风湿病协会委员会1958年修订版。
Ann Rheum Dis. 1959 Mar;18(1):49-51; French transl 51-2; Spanish transl 52-3.
5
Measurement of spinal posture and range of spinal movement.脊柱姿势及脊柱活动范围的测量。
Ann Phys Med. 1967 Aug;9(3):103-10. doi: 10.1093/rheumatology/9.3.103.
6
Normal range of spinal mobility. An objective clinical study.脊柱活动度的正常范围。一项客观的临床研究。
Ann Rheum Dis. 1971 Jul;30(4):381-6. doi: 10.1136/ard.30.4.381.
7
A psychological study of rheumatoid arthritis and selected controls.一项关于类风湿性关节炎及选定对照的心理学研究。
J Chronic Dis. 1971 Mar;23(10):791-801. doi: 10.1016/0021-9681(71)90009-9.
8
Personality, disease parameters and medication in rheumatoid arthritis.类风湿关节炎中的人格、疾病参数与药物治疗
J Chronic Dis. 1971 Aug;24(6):363-72. doi: 10.1016/0021-9681(71)90136-6.
9
Spondylometry in a normal population and in ankylosing spondylitis.正常人群和强直性脊柱炎患者的脊柱测量
Rheumatol Rehabil. 1973 Aug;12(3):135-42. doi: 10.1093/rheumatology/12.3.135.
10
Clinico-pharmacological studies and clinical evaluation of flurbiprofen. A new non-steroidal antirheumatic agent.氟比洛芬的临床药理学研究与临床评价。一种新型非甾体类抗风湿药。
Ann Rheum Dis. 1972 Jul;31(4):319-24. doi: 10.1136/ard.31.4.319.
Zotero 插件